NeoGenomics, Inc.
Income Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|
| Revenue | $240.3M | $231.8M | $5.0M | $5.0M | $5.0M | $5.0M |
| Cost of Revenue | $138.3M | $133.7M | — | — | — | — |
| Gross Profit | $102.0M | $98.1M | $43.8M | $40.7M | $31.7M | $26.8M |
| Gross Margin | 42.4% | 42.3% | 875.1% | 814.3% | 634.7% | 536.7% |
| Operating Expenses | ||||||
| Research & Development | $3.6M | $4.6M | $4.2M | $2.7M | $2.4M | $2.3M |
| SG&A Expense | $70.4M | $63.9M | $33.6M | $23.8M | $17.4M | $15.8M |
| Operating Income | $2.9M | $2.2M | $-5.6M | $2.2M | $3.2M | $1.2M |
| Operating Margin | 1.2% | 0.9% | -112.7% | 44.4% | 63.5% | 24.2% |
| Interest Expense | $5.5M | — | $854.0K | $985.0K | $989.0K | $1.1M |
| Pretax Income | $-2.7M | $-7.8M | $-4.5M | $1.3M | $2.2M | $65.0K |
| Income Tax Expense | $-2.3M | $-1.7M | $-2.0M | $157.0K | $152.0K | $0 |
| Net Income | $-396.0K | $-6.1M | $-2.5M | $1.1M | $2.0M | $65.0K |
| Net Margin | -0.2% | -2.6% | -50.7% | 22.6% | 40.7% | 1.3% |
| EPS (Basic) | $-0.14 | $-0.40 | $-0.04 | $0.02 | $0.04 | $0.00 |
| EPS (Diluted) | $-0.14 | $-0.40 | $-0.04 | $0.02 | $0.04 | $0.00 |
| Shares Outstanding (Basic) | 79.4M | 77.5M | 60.5M | 53.5M | 48.3M | 45.0M |
| Shares Outstanding (Diluted) | 79.4M | 77.5M | 60.5M | 56.0M | 52.8M | 48.7M |
| Dividends Per Share | — | — | — | — | — | — |